A phase I/randomized phase II study of MLN0128 vs. Pazopanib in patients with locally advanced/unresectable and/or metastatic sarcoma: Alliance A091304
   Google Scholar   
Citation:
J Clin Oncol vol 34 (suppl) abstr TPS11073
Meeting Instance:
ASCO 2016
Year:
2016
Type:
Abstract
Sub type:
Poster General
Funding:
NCTN
Endpoint:
No-Endpoint
Analysis:
Trial-Description-Only
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
epub
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Parents:
None
Children:
None
Program:
OGC
Primary Committee:
Experimental
Sec. Committees:
   
Pharmas:
 
Grants:
U10CA180821, U10CA180882  
Corr. Author:
 
Authors:
           
Networks:
COLUMBIA, LAPS-MN026, LAPS-NY016   
Study
Alliance-A091304
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
1/2
Keywords: